Application of traditional Chinese medicine composition in preparation of anti-coronavirus medicine
Through the preparation process of traditional Chinese medicine composition based on "Liver Re Puqing San", the problem of lack of effective anti-coronavirus drugs in the prior art has been solved, and effective inhibition and treatment of coronavirus has been achieved, with high efficiency, safety and low price.
Patent Information
- Application Number
- CN202311834994.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-28
- Publication Date
- 2025-03-18
AI Technical Summary
The prior art lacks efficient, safe and low-coronavirus drugs, especially for a wide variety of coronavirus species, highly variability and pathogenicity.
Through the extracts and preparations of traditional Chinese medicine compositions prepared based on the basic prescription of "Liver Re Puqing San", drugs with anti-coronavirus and treatment of diseases caused by coronavirus are prepared using medicinal materials such as Tianzhu yellow, safflower, and cloves, and volatile oil extraction and extracting technology.
Traditional Chinese medicine compositions have a significant inhibitory effect on coronaviruses such as HCoV-229E and MHV-A59, which can reduce viral load, reduce inflammatory factors, and effectively treat hepatitis and pneumonia caused by coronavirus.